Replies to post #40991 on DNAprint Genomics (DNAG)

[SaveTheWorld]

"Our relationship with Biofrontera will result in a new pharmaceutical pipeline for DNAPrint genomics,"

That is because they purchased an investment in Biofrontera. The statement above is misleading, in my opinion. That is why they consider this a "new pharmaceutical pipeline for DNAPrint". If DNAG had purchased a .18% stake in Pfizer, they would be claiming a "new pharmaceutical pipeline" also. It doesn't mean that DNAP will ever work on any of those compounds. Remember, we have had to purchase licensing agreements for the 2 compounds DNAG is trying to develop- I certainly don't think Biofrontera would be any different. So I stand by my earlier statement....:""And unless Biofrontera wants to just share these drugs with an american Penny Stock, then it's nothing more than just an investment." "